Eliezer Lappots-Abreu, HHI Executive Director, Wins Lead2030 Award

Eliezer (Eli) Lappots-Abreu has become the first Dominican recipient of the Lead2030 Award from AstraZeneca and One Young World. This award recognizes leaders aged 30 and under who are committed to achieving the Sustainable Development Goals. In partnership with the United Nations, One Young World has adopted 17 Sustainable Development Goals, ranging from ending hunger to addressing climate change, with the aim of making them a reality by 2030. At only 30 years old, Eli will represent HHI and the Dominican Republic at the One Young World Summit in Montreal this fall.

Since 2019, Eli has driven the expansion of HHI’s programming and impact in the Dominican Republic. Before his career with HHI, Eli led efforts worldwide to defend human rights and social justice to benefit marginalized populations. He continues to advocate for accessible, quality health services in underserved communities.

The Lead2030 grant recognizes Eli for his work with HHI in addressing the Sustainable Development Goal of good health and well-being. Through the Movimiento Mujeres initiative, HHI aims to combat the gender health disparities prevalent in the Dominican Republic. Eli has developed a solution that trains young women with the knowledge to promote healthy habits, reduce risk factors for chronic diseases, and provide primary care services for their communities, including screenings, medication delivery, and referrals to specialists. Additionally, women and girls at risk of developing chronic diseases are identified for services such as support groups, free preventive testing, and vaccinations. This project aims to reach 100,000 women and girls in 2024.

Congratulations, Eli, on this prestigious honor. HHI is proud to call you one of our own.

The content of this publication has not been approved by the United Nations and does not reflect the views of the United Nations, its officials, or Member States.

Leave a Reply

Discover more from Health Horizons International

Subscribe now to keep reading and get access to the full archive.

Continue reading